Abstract
The tumor-associated carbohydrate antigen/hapten Thomsen-nouveau (Tn; αNAc-ONH2) was conjugated to a zwitterionic capsular polysaccharide, PS A1, from commensal anaerobe Bacteroides fragilis ATCC 25285/NCTC 9343 for the development of an entirely carbohydrate cancer vaccine construct and probed for immunogenicity. This communication discloses that murine anti-Tn IgG3 antibodies both bind to and recognize human tumor cells that display the Tn hapten. Furthermore, the sera from immunization of mice with Tn-PS A1 contain cytokine interleukin 17 (IL-17A), which is known to possess anti-tumor function and represents a striking difference to an IL-2, and IL-6 profile obtained with anti-PS A1 sera.
Original language | English (US) |
---|---|
Pages (from-to) | 581-585 |
Number of pages | 5 |
Journal | Cancer Immunology, Immunotherapy |
Volume | 61 |
Issue number | 4 |
DOIs | |
State | Published - Apr 2012 |
Externally published | Yes |
Keywords
- Antigen
- Carbohydrates
- Flow cytometry
- Interleukin 17
- Tumor
- Vaccine
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
- Oncology
- Cancer Research